Boston Scientific Corp.
1 Boston Scientific Place
Natick
MA
01760-1537
United States
Product(s):
Manufactures stents, pacemakers, pain management and endosurgery products
Employees:
25000
Ownership:
Public
Exchange:
NYSE
symbol:
BSX
2004 Revenue:
$5,624,000,000
2005 Revenue:
$6,283,000,000
2006 Revenue:
$7,821,000,000
2007 Revenue:
$8,357,000,000
2008 Revenue:
$8,050,000,000
Yahoo Quotes:
President:
James R. Tobin Management:
James R. Tobin, Director/President/CEO
Donald S. Baim, EVP/CMO/CSO
Brian R. Burns, SVP-Quality
Jeffrey D. Capello, SVP/CAO/Corporate Controller
Fredericus A. Colen, EVP/President-Cardiac Rhythm Management
Paul Donovan, SVP- Corporate Communications
Jim Gilbert, EVP-Strategy & Business Development
William H. (Hank) Kucheman, SVP/President-Cardiovascular
Samuel R. Leno, EVP-Finance & Information Systems/CFO
William F. McConnell Jr., SVP-Sales, Marketing & Business Strategy, cardiac rhythm management
David McFaul, SVP-International
Stephen F. Moreci, SVP/President-Endosurgery
Michael Onuscheck, SVP/President-Neuromodulation
Timothy A. Pratt, EVP/Secretary, General Counsel
Kenneth J. Pucel, EVP-Operations
Lucia Luce Quinn, EVP-HR
Boston Scientific Corp.
Printer-friendly versionPermalink
Top News Stories
RECENT BLOG POSTS
- Weekly Wireless Roundup: Three iPhone hospitals
- MedGadget's MedTech Monday: Avatar in the OR
- MedGadget's MedTech Monday: Flexible rubber sheets to power implantable devices?
- Weekly Wireless Roundup: Is Apple iPad the device healthcare has waited for?
- The case against EMRs
- Two agencies that could stand a temporary freeze
- Abiomed posts Impella procedure video
- MedGadget's MedTech Monday: Wireless sensor detects pH, glucose levels in exhaled breath
- MobiHealthNews Weekly Wireless Roundup: Four pharma companies test GlowCaps
- Clearing a path to reimbursement, Part II
Navigation
